Video

Distinguishing Myeloma from Smoldering Myeloma

The definition of smoldering myeloma was reworked in recent years.

Sagar Lonial, M.D., professor and chair of Hematology & Medical Oncology at Emory University School of Medicine, and Chief Medical Officer of the Winship Cancer Institute of Emory University, discusses the classification of different types of myeloma.

The risk levels — high, moderate or low – among patients with smoldering myeloma can be determined through a bone marrow biopsy, which may affect treatment decisions. Therefore, the Myeloma Working Group reworked the classifications for myeloma and smoldering myeloma, which is an important distinction for patients and their providers to establish, Lonial said.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Watch oncology dietitian Kenisha Parikh prepare creamy lentil soup, a soothing, protein-packed recipe to help ease side effects during treatment.